OrphoMed Competitors and Similar CompaniesClear all

OrphoMed's competitors and similar companies include BioMarin Pharmaceutical, CSL Behring, Fujifilm Diosynth Biotechnologies and Zentiva.

	OrphoMed OrphoMed is a clinical-stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles.	BioMarin Pharmaceutical BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.	CSL Behring CSL Behring is a provider of life-saving medicines.	Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry.	Zentiva Zentiva is a company that develops and manufactures generic medicines.
Founding Date	Founding Date 2015	Founding Date 1997	Founding Date 1904	Founding Date 2011	Founding Date 2003
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations San Francisco, US HQ	Locations San Rafael, US HQ Martínez, AR Crows Nest, AU Sao Paulo, BR Bogotá, CO Kronberg Im Taunus, DE Wanchai, HK see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more	Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US	Locations CZ HQ Tallinn, EE Paris, FR Mumbai, IN Milano, IT Milano, IT Rīga, LV see more
Employees	Employees 10	Employees 3,0015% increase	Employees 7,5692% decrease	Employees 5,3942% increase	Employees 3,4721% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $3.2b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) Kč2.3b (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods $717.4m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods Kč807.2m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit $2.5b (FY, 2025)	Gross profit $4.5b (FY, 2020)	Gross profit N/A	Gross profit Kč1.5b (FY, 2021)
Net income	Net income N/A	Net income $348.9m (FY, 2025)	Net income N/A	Net income N/A	Net income (Kč831.2m) (FY, 2021)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries 100 (Dec, 2020)	Countries N/A	Countries 35 (Apr, 2023)
Patent Applications	Patent Applications N/A	Patent Applications 426 (FY, 2016)	Patent Applications 3 (Dec, 2020)	Patent Applications N/A	Patent Applications N/A
Trademark Applications	Trademark Applications N/A	Trademark Applications N/A	Trademark Applications 1 (Dec, 2020)	Trademark Applications N/A	Trademark Applications 4 (Apr, 2023)
Trademarks	Trademarks N/A	Trademarks N/A	Trademarks 4 (Dec, 2020)	Trademarks N/A	Trademarks 252 (Apr, 2023)
Funding
Total funding raised	Total funding raised $ 41.8m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 850m	Total funding raised N/A